CIM
ACH

Contravisory Investment Management’s Accendra Health ACH Stock Holding History

Contravisory Investment Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-125
Closed -$4K – 354
2022
Q2 		$4K Hold
125
– – ﹤0.01% 303
2022
Q1 		$6K Buy
+125
New +$5.37K ﹤0.01% 274

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Contravisory Investment Management's ACH Position: Q3 2022 in Review

Contravisory Investment Management sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 125 shares — an estimated $4K sold.

Contravisory Investment Management first reported a position in ACH in Q1 2022 and held it in 2 quarters. The position peaked at $6K in Q1 2022. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Contravisory Investment Management reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Contravisory Investment Management sold 125 Accendra Health shares in Q3 2022, an estimated $4K.
  • Contravisory Investment Management first reported a position in Accendra Health in Q1 2022 and held it in 2 quarters.
  • Contravisory Investment Management's Accendra Health position peaked at $6K in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Contravisory Investment Management's 13F filing for Q3 2022, filed 12 Oct 2022.